A Computational Modeling of ADLumin Chemiluminescence: Oxygenation and Dioxetanone Formation

15 December 2025, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.

Abstract

ADLumin is a new class of turn-on chemiluminescent probes that have shown increased luminescent intensity in the presence of amyloid beta (Aβ) plaques, which are commonly associated with Alzheimer’s disease (AD). ADLumin shares an imidazopyrazinone (IPO) moiety with the well known Cypridina luciferin, which reacts with O2 and produces bioluminescence. While the reaction mechanism for many other luciferins has been studied extensively, the chemiluminescent mechanism for ADLumin molecules has yet to be modeled computationally. In this work, we focus on the exploration of potential reaction mechanism for the dioxetanone formation in ADLumin-5, which has shown stronger chemiluminescence in the presence of Aβ plaques than other ADLumin molecules. Our density functional theory calculations predict thermally accessible energy barriers for three separate reaction paths, which we refer to as A, B, and B’, respectively. These mechanisms differ in O2 binding sites, all with comparable singlet-triplet minimum energy crossing point (MECP) energies. While paths A and B are similar to those previously studied for the oxidation of Cypridina luciferin, our calculations revealed a bifurcating crossing point connecting path B and an alternative path B’. Overall, our results suggest that path B is the most energetically favorable among the three pathways for ADLumin-5.

Keywords

Chemiluminescence

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.